• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者进餐及餐后高血糖时胰高血糖素样肽-1 的反应。

Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients.

机构信息

Section of Geriatric Cardiology, Department of Critical Care Medicine and Surgery, University of Florence and Azienda Ospedaliero- Universitaria Careggi, 50134 Florence, Italy.

出版信息

J Endocrinol Invest. 2010 Mar;33(3):147-50. doi: 10.1007/BF03346573. Epub 2009 Sep 11.

DOI:10.1007/BF03346573
PMID:19783893
Abstract

BACKGROUND

The impaired response of glucagonlike peptide-1 (GLP-1) to meals in diabetic patients can contribute to the pathogenesis of impaired insulin secretion and post-prandial hyperglycemia. This study is aimed at the assessment of the relationship between meal-induced GLP-1 and post-prandial hyperglycemia in Type 2 diabetic patients.

METHODS

Twenty-one drug-naïve Type 2 diabetic patients were studied. Blood glucose and active GLP-1 levels were measured 0, 30, 60, 90, and 120 min after a standard test meal. A continuous glucose monitoring (CGM) system was applied for the following 3 days. Nutrient intake at each meal was calculated on the basis of patients' food records. For each patient, post-prandial 120-min glucose incremental area under the curve (iAUC) was included in linear regression model exploring its relationship with total energy and carbohydrate intake, and the angular coefficient for total energy (EAC) and carbohydrate (CAC) was calculated.

RESULTS

GLP-1 levels peaked 30 min after the test meal. Logarithmically transformed 60-min GLP-1 iAUC showed a significant inverse correlation with glycated hemoglobin (HbA1c) (p<0.01). A significant inverse correlation of 60-min GLP-1 iAUC was also observed with EAC and CAC (both p<0.01), meaning that patients with a lower GLP-1 response to the test meal had a higher increment of post-prandial glucose for each additional unit of total energy or carbohydrate intake.

CONCLUSIONS

In Type 2 diabetic patients, a lower GLP-1 response to meals is associated with a higher HbA1c, and with a greater degree of meal-induced hyperglycemia, both in a meal test and during CGM in "real-life" conditions.

摘要

背景

糖尿病患者对胰高血糖素样肽-1(GLP-1)的反应受损可能导致胰岛素分泌受损和餐后高血糖。本研究旨在评估 2 型糖尿病患者餐后 GLP-1 与餐后高血糖之间的关系。

方法

研究了 21 例初治的 2 型糖尿病患者。在标准测试餐后 0、30、60、90 和 120 分钟测量血糖和活性 GLP-1 水平。在接下来的 3 天内应用连续血糖监测(CGM)系统。根据患者的食物记录计算每餐的营养摄入量。对于每个患者,餐后 120 分钟血糖增量曲线下面积(iAUC)被纳入线性回归模型,以探索其与总能量和碳水化合物摄入量的关系,并计算总能量(EAC)和碳水化合物(CAC)的角系数。

结果

GLP-1 水平在测试餐后 30 分钟达到峰值。对数转换的 60 分钟 GLP-1 iAUC 与糖化血红蛋白(HbA1c)呈显著负相关(p<0.01)。60 分钟 GLP-1 iAUC 与 EAC 和 CAC 也呈显著负相关(均 p<0.01),这意味着对测试餐的 GLP-1 反应较低的患者,每增加单位总能量或碳水化合物摄入,餐后血糖升高幅度更大。

结论

在 2 型糖尿病患者中,餐后 GLP-1 反应较低与较高的 HbA1c 以及更大程度的餐后高血糖有关,无论是在餐试还是在 CGM 期间的“真实生活”条件下。

相似文献

1
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients.2 型糖尿病患者进餐及餐后高血糖时胰高血糖素样肽-1 的反应。
J Endocrinol Invest. 2010 Mar;33(3):147-50. doi: 10.1007/BF03346573. Epub 2009 Sep 11.
2
Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.四周的血糖近乎正常化对2型糖尿病患者餐后胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性促胰岛素多肽(GIP)的分泌没有影响,但会增强胰腺β细胞对进食的反应性。
Diabet Med. 2008 Nov;25(11):1268-75. doi: 10.1111/j.1464-5491.2008.02579.x.
3
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.2 型糖尿病患者胰高血糖素样肽-1 的分泌:临床研究的系统评价和荟萃分析。
Diabetologia. 2013 May;56(5):965-72. doi: 10.1007/s00125-013-2841-0. Epub 2013 Feb 3.
4
Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.超重/肥胖受试者的餐后胰高血糖素样肽-1、胰岛素、胰高血糖素、C 肽和血糖反应受膳食成分的影响。
Eur J Nutr. 2017 Apr;56(3):1053-1062. doi: 10.1007/s00394-016-1154-8. Epub 2016 Jan 12.
5
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.西格列汀对 1 型糖尿病患者餐后胰高血糖素和 GLP-1 水平的影响:一项由研究者发起的、双盲、随机、安慰剂对照试验。
Endocr Pract. 2013 Jan-Feb;19(1):19-28. doi: 10.4158/EP12100.OR.
6
Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.进食刺激的胰高血糖素释放与餐后血糖水平相关,且不干扰新诊断1型糖尿病儿童和青少年的血糖控制。
J Clin Endocrinol Metab. 2007 Aug;92(8):2910-6. doi: 10.1210/jc.2007-0244. Epub 2007 May 22.
7
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.皮下注射肠促胰岛素激素胰高血糖素样肽-1可消除非胰岛素依赖型糖尿病患者的餐后血糖。
Diabetes Care. 1994 Sep;17(9):1039-44. doi: 10.2337/diacare.17.9.1039.
8
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.米格列醇对肥胖2型糖尿病患者胰高血糖素样肽-1分泌及食欲感觉的影响。
Diabetes Obes Metab. 2002 Sep;4(5):329-35. doi: 10.1046/j.1463-1326.2002.00219.x.
9
Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes.胰高血糖素样肽1诱导的胰岛素分泌在人类2型(非胰岛素依赖型)糖尿病中早期受损的证据。
Horm Metab Res. 2002 Mar;34(3):150-4. doi: 10.1055/s-2002-23199.
10
Decreased active GLP-1 response following large test meal in patients with type 1 diabetes using bolus insulin analogues.1 型糖尿病患者使用胰岛素类似物进行大剂量推注后,GLP-1 反应活性降低。
Endocr J. 2011;58(10):905-11. doi: 10.1507/endocrj.k11e-125. Epub 2011 Aug 30.

引用本文的文献

1
Ramadan and Diabetes: A Narrative Review and Practice Update.斋月与糖尿病:叙述性综述及实践更新
Diabetes Ther. 2020 Sep 9:1-44. doi: 10.1007/s13300-020-00886-y.
2
Ramadan and Diabetes: A Narrative Review and Practice Update.斋月与糖尿病:叙述性综述及实践更新
Diabetes Ther. 2020 Nov;11(11):2477-2520. doi: 10.1007/s13300-020-00886-y. Epub 2020 Sep 9.
3
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.在体重指数低于30kg/m²的2型糖尿病患者中,尿胆汁酸与血糖控制有关。

本文引用的文献

1
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.肠促胰岛素系统:2型糖尿病中的胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂
Lancet. 2006 Nov 11;368(9548):1696-705. doi: 10.1016/S0140-6736(06)69705-5.
2
Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.2型糖尿病患者的血浆二肽基肽酶-IV活性与糖化血红蛋白水平呈正相关,但不受食物摄入的急性影响。
Eur J Endocrinol. 2006 Sep;155(3):485-93. doi: 10.1530/eje.1.02221.
3
Glucagon-like peptide 1 (GLP-1) and metabolic diseases.
PLoS One. 2014 Apr 15;9(4):e93540. doi: 10.1371/journal.pone.0093540. eCollection 2014.
4
Impact of incretin on early-phase insulin secretion and glucose excursion.肠促胰岛素对早期胰岛素分泌和血糖波动的影响。
Endocrine. 2013 Oct;44(2):403-10. doi: 10.1007/s12020-012-9867-9. Epub 2013 Jan 3.
5
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy.从GLP-1受体激动剂和DPP-4抑制剂治疗的理论到临床实践
Exp Diabetes Res. 2011;2011:898913. doi: 10.1155/2011/898913. Epub 2011 Jun 23.
胰高血糖素样肽1(GLP-1)与代谢性疾病。
J Endocrinol Invest. 2005 Sep;28(8):746-58. doi: 10.1007/BF03347560.
4
Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.高血糖会增加糖尿病患者体内二肽基肽酶IV的活性。
Diabetologia. 2005 Jun;48(6):1168-72. doi: 10.1007/s00125-005-1749-8. Epub 2005 Apr 29.
5
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents.胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性促胰岛素多肽(GIP)的结构修饰类似物作为未来的抗糖尿病药物。
Curr Pharm Des. 2004;10(29):3651-62. doi: 10.2174/1381612043382774.
6
Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.胃抑制多肽和胰高血糖素样肽-1在2型糖尿病发病机制中的作用
Diabetes. 2004 Dec;53 Suppl 3:S190-6. doi: 10.2337/diabetes.53.suppl_3.s190.
7
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells.
Biochem Biophys Res Commun. 2003 Oct 10;310(1):28-31. doi: 10.1016/j.bbrc.2003.08.111.
8
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.2型糖尿病患者胰高血糖素样肽-1分泌受损的决定因素。
J Clin Endocrinol Metab. 2001 Aug;86(8):3717-23. doi: 10.1210/jcem.86.8.7750.
9
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects.
Diabetes Care. 2001 Mar;24(3):489-94. doi: 10.2337/diacare.24.3.489.
10
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.2型糖尿病患者餐后完整生物活性胰高血糖素样肽1浓度降低。
Diabetes. 2001 Mar;50(3):609-13. doi: 10.2337/diabetes.50.3.609.